4//SEC Filing
Sama Rinda 4
Accession 0001562180-22-006075
CIK 0001603756other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:48 PM ET
Size
17.7 KB
Accession
0001562180-22-006075
Insider Transaction Report
Form 4
Axonics, Inc.AXNX
Sama Rinda
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-10$25.82/sh+8,301$214,332→ 79,136 total - Sale
Common Stock
2022-08-10$69.35/sh−24,478$1,697,486→ 64,030 total - Exercise/Conversion
Common Stock
2022-08-10$14.19/sh+16,177$229,552→ 70,835 total - Exercise/Conversion
Common Stock
2022-08-10$14.19/sh+9,372$132,989→ 88,508 total - Sale
Common Stock
2022-08-10$70.12/sh−9,372$657,165→ 54,658 total - Exercise/Conversion
Stock Options (Right to buy)
2022-08-10−25,549→ 11,019 totalExercise: $14.19Exp: 2029-01-30→ Common Stock (25,549 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2022-08-10−8,301→ 9,962 totalExercise: $25.82Exp: 2029-12-12→ Common Stock (8,301 underlying)
Holdings
- 4,000(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $68.98 to $69.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $70.00 to $70.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 30th, 2020, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 30th, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- [F5]The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date.
Documents
Issuer
Axonics, Inc.
CIK 0001603756
Entity typeother
Related Parties
1- filerCIK 0001756399
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 7:48 PM ET
- Size
- 17.7 KB